Pharmaceutical supply chains are becoming increasingly vulnerable to a range of disruptions. From geopolitical upheavals to natural disasters, the unpredictability of the modern world demands ...

If a pharmaceutical manufacturer is unable to provide that data, products cannot legally be moved to the next step in the ...

The integration of AI technologies aims to reduce the time and cost associated with bringing new drugs to market, addressing a critical need within the pharmaceutical industry. Artificial intelligence ...

Creating contingency plans against geopolitical uncertainty was a key theme at the 2024 Outsourcing in Clinical Trials and ...

The health care and pharmaceutical industries have undergone impressive developments in recent years with the rise of ...

Biocodex is a French, family-owned, pharmaceutical company that has grown from microbiota pioneer to an international leader with its diverse portfolio focused on three areas of expertise: microbiota ...

Conclave - 2024 champions global supply chain resilience and quality excellence through collaborations: Shardul Nautiyal, ...

Mr. Adak has earned a reputation as a visionary leader, constantly pushing the boundaries of what is possible in the API ...

Bachem's Pascal Degen explains the challenges faced by CDMOs in a volatile, uncertain, complex and ambiguous (VUCA) world.